The potential role of pro-inflammatory cytokines in brain damage from hypoperfusion is suggested by the observation of a cytokine storm after stroke [12,13,14] and the efficacy of the IL-1β antibody, canakinumab, in stroke protection [15]. The gene discussed is IL1B; the disease is Stroke.